CALA earnings strangle | CALA Message Board Posts

Calithera Biosciences, Inc.

  CALA website
  • Create your FREE account today!

    Username:Up to 23 characters, no spaces or apostrophes allowed.

    Password:6-20 characters.

    Confirm PasswordRetype Your Password.

    Email:You will receive an email to confirm this account,so please enter a valid address (and double cheek for typos!)

    I have read and agree to the InvestorVillage User Agreement.

CALA   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  387 of 1175  at  1/9/2017 9:35:10 PM  by


The following message was updated on 1/9/2017 9:45:52 PM.

 In response to msg 386 by  drkent3
view thread

Re: CALA earnings strangle

I took it as a hindsight-oriented... woulda, coulda, shoulda type piece - but figured I'd toss it out so somebody like you might explain it to me. Regardless of the actual nature of the recent BMY collaboration announcement, the recent trial positivity, and the high probability that at least some trial costs will be shared going forward...the only measurable impact we've witnessed has been the sentiment surrounding the stock. We are still quite ways from improvement to revenue. That strangle may have worked when sentiment ran continually lower due to reported losses, but I think we'll have another positive surprise in a few days when Q4 IH holdings are reported. Sentiment will be back on high...

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 97
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2016 All rights reserved. User Agreement
Financial Market Data provided by